Afya Limited Appoints KPMG as New Auditor

An announcement from Afya ( (AFYA) ) is now available.

On June 2, 2025, Afya Limited announced a change in its independent registered public accounting firm, with KPMG Auditores Independentes Ltda. replacing Ernst & Young Auditores Independentes S/S Ltda. This strategic decision, approved by the board of directors and recommended by the audit committee, marks a significant shift in the company’s auditing services. KPMG will begin its engagement by reviewing the company’s quarterly information for the second quarter of 2025, potentially impacting Afya’s financial reporting processes and stakeholder confidence.

The most recent analyst rating on (AFYA) stock is a Hold with a $25.00 price target. To see the full list of analyst forecasts on Afya stock, see the AFYA Stock Forecast page.

Spark’s Take on AFYA Stock

According to Spark, TipRanks’ AI Analyst, AFYA is a Outperform.

Afya presents a strong investment opportunity with robust financial performance and strategic growth. The company benefits from solid revenue and margin growth, efficient cash flow management, and positive technical indicators. While its valuation is reasonable, some challenges such as decreased active users in specific segments and increased tax expenses should be monitored. Overall, Afya’s strong fundamentals and strategic initiatives position it well for future growth.

To see Spark’s full report on AFYA stock, click here.

More about Afya

Afya Limited is a leading medical education group in Brazil, known for its extensive number of medical school seats. The company provides a comprehensive, physician-centric ecosystem that supports students and physicians throughout their careers, from medical school to continuing education and digital healthcare solutions.

Average Trading Volume: 120,062

Technical Sentiment Signal: Buy

Current Market Cap: $1.65B

For a thorough assessment of AFYA stock, go to TipRanks’ Stock Analysis page.